Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: MERCK SHARP & DOHME LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-06-07 to 2023-09-30
Current total value of award: $2205000834
Description: COVID-19 ACTION  ORAL ANTIVIRAL  MK-4482 (MOLNUPIRAVIR)